4.8 Review

The BCG Vaccine for COVID-19: First Verdict and Future Directions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers

Magali Noval Rivas et al.

Summary: In this study of healthcare workers, those with a history of BCG vaccination had lower seroprevalence of anti-SARS-CoV-2 IgG and reported fewer COVID-19-related symptoms compared to those without BCG vaccination. This suggests a potential protective effect of BCG vaccination against SARS-CoV-2 infection, warranting further large-scale clinical trials for confirmation.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

Letter Medicine, General & Internal

SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults

Uri Hamiel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, General & Internal

Considering BCG vaccination to reduce the impact of COVID-19

Nigel Curtis et al.

LANCET (2020)

Article Biochemistry & Molecular Biology

Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly

Evangelos J. Giamarellos-Bourboulis et al.

Article Multidisciplinary Sciences

BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)

Luis E. Escobar et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Letter Multidisciplinary Sciences

The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection

Vincenzo Patella et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Cell Biology

Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study

Simone J. C. F. M. Moorlag et al.

CELL REPORTS MEDICINE (2020)

Review Infectious Diseases

Non-specific effects of BCG vaccine on viral infections

S. J. C. F. M. Moorlag et al.

CLINICAL MICROBIOLOGY AND INFECTION (2019)

Review Immunology

The Humoral Immune Response to BCG Vaccination

Rachel Tanner et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Microbiology

Oncolytic bacteria: past, present and future

Sergio Rius-Rocabert et al.

FEMS MICROBIOLOGY LETTERS (2019)

Article Medicine, General & Internal

Prevention of M-tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

E. Nemes et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Public, Environmental & Occupational Health

Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971-2010

Andreas Rieckmann et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)

Article Biotechnology & Applied Microbiology

A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus

Emma Rey-Jurado et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)

Review Immunology

The Recombinant Bacille Calmette-Guerin Vaccine VPM1002: Ready for Clinical Efficacy Testing

Natalie E. Nieuwenhuizen et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Biotechnology & Applied Microbiology

Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms

Lu Zhang et al.

MOLECULAR THERAPY (2016)

Article Multidisciplinary Sciences

Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine

Vanessa Tran et al.

SCIENTIFIC REPORTS (2016)

Article Immunology

BCG-induced trained immunity in NK cells: Role for non-specific protection to infection

Johanneke Kleinnijenhuis et al.

CLINICAL IMMUNOLOGY (2014)

Article Immunology

Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity

Johanneke Kleinnijenhuis et al.

JOURNAL OF INNATE IMMUNITY (2014)

Article Multidisciplinary Sciences

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

Johanneke Kleinnijenhuis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Microbiology

Trained Immunity: A Memory for Innate Host Defense

Mihai G. Netea et al.

CELL HOST & MICROBE (2011)

Article Pediatrics

The non-specific effects of vaccines

Frank Shann

ARCHIVES OF DISEASE IN CHILDHOOD (2010)

Article Oncology

The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer

Priscila M. Andrade et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)

Article Multidisciplinary Sciences

Genome plasticity of BCG and impact on vaccine efficacy

Roland Brosch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Medicine, General & Internal

Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa

I Kristensen et al.

BRITISH MEDICAL JOURNAL (2000)